The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Bevacizumab     Injury: Lung infection     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 9     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
81331126 Bevacizumab Lung infection ROCHE 0.00 F 0 20160912 US
86818712 Bevacizumab Lung infection ROCHE 74.84 YR M 85 KG 20160914 US
94583572 Bevacizumab Lung infection ROCHE 66.00 YR F 54 KG 20160929 US
125732041 Bevacizumab Lung infection ROCHE 0.00 0 20160720 JP
127361271 Bevacizumab Lung infection ROCHE 55.00 YR M 71 KG 20160913 US
127408921 Bevacizumab Lung infection ROCHE 59.29 YR M 71 KG 20160914 US
127415161 Bevacizumab Lung infection ROCHE 55.00 YR M 76 KG 20160914 US
127450631 Bevacizumab Lung infection ROCHE 61.00 YR M 66 KG 20160915 US
127977921 Bevacizumab Lung infection ROCHE 55.00 YR F 76 KG 20160930 US

  |<   1/2   << Previous Page   Page 1  

Total Records: 9     Number of Pages: 1

Execution Time: 0.13970112800598 seconds (ucode:5111218). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.